ClinConnect ClinConnect Logo
Search / Trial NCT06772519

Relieving Surgical Pain and Nausea with Light Therapy

Launched by NURAN AYŞEN PAMIR AKSOY · Jan 10, 2025

Trial Information

Current as of October 03, 2025

Enrolling by invitation

Keywords

Colored Lens Glasses Postoperative Pain Organ Donor Kidney Transplantation Postoperative Nausea Blue Light Green Light

ClinConnect Summary

This study is testing whether wearing colored light glasses after kidney donation surgery can help reduce pain and nausea. Participants are randomly assigned to one of four groups: blue lens glasses, green lens glasses, clear (colorless) lens glasses, or no glasses at all. The researchers will compare the effects of the colored glasses to the clear glasses and to not wearing glasses, to see if the colors make a difference in comfort after surgery. Participants wear the glasses for at least 8 hours per day from after they’re moved to the hospital ward until they go home, and they report their pain and nausea every 2 hours on the first postoperative day and every 4 hours on the second day.

Who can join: adults who donate a kidney, can wear glasses, can communicate with the study team, and are not color blind. People who develop postoperative complications during the study period or who cannot wear glasses are not eligible. If you participate, you’ll be asked to provide quick pain and nausea ratings during your hospital stay. The trial is taking place at Acibadem Atakent Hospital in Istanbul, Turkey, and is currently enrolling by invitation with results not yet available.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being a donor for kidney transplantation
  • Not having an obstacle to wearing glasses
  • Being able to communicate verbally
  • Exclusion Criteria:
  • Being color blind • Developing post-operative complications during the study period

About Nuran Ayşen Pamir Aksoy

Nuran Ayşen Pamir Aksoy is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong background in clinical pharmacology and extensive experience in trial design and implementation, she leads initiatives that prioritize safety, efficacy, and regulatory compliance. Her work focuses on fostering collaboration among multidisciplinary teams, ensuring rigorous adherence to ethical standards, and leveraging innovative methodologies to facilitate groundbreaking studies in various therapeutic areas. Through her leadership, she aims to contribute significantly to the development of new treatments and enhance the overall quality of clinical research.

Locations

Istanbul, Atakent, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported